Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian David Etessami

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 14, 2026
Advancing Antibody-Drug Conjugates: Current Perspectives and Future DirectionsJulian David Etessami, Carmine Valenza, Anthony W Tolcher, et al.
Cancer Treatment Reviews|June 29, 2026
Treatment of breast cancer brain metastases in the era of novel drugsJulian David Etessami, Giovanni Dalla Via, Emanuela Ferraro, et al.
Expert Opinion on Pharmacotherapy|May 22, 2026
Oral selective estrogen receptor degraders (SERDs) for the treatment of hormone receptor-positive, HER2-negative breast cancer title: oral selective estrogen receptor degraders (SERDs) for the treatment of hormone receptor-positive, HER2-negative breast cancerJulian David Etessami, Carmine Valenza, Pier Paolo Maria Berton Giachetti, et al.
Critical Reviews in Oncology/Hematology|April 12, 2026
Epidermal Growth Factor Receptor (EGFR) atypical mutations in Non-Small-Cell Lung Cancer (NSCLC): 'where the streets have no name'Gianluca Spitaleri, Pamela Trillo Aliaga, Gianluca Alessio Mariani, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 14, 2026
Advancing Antibody-Drug Conjugates: Current Perspectives and Future DirectionsJulian David Etessami, Carmine Valenza, Anthony W Tolcher, et al.
Cancer Treatment Reviews|June 29, 2026
Treatment of breast cancer brain metastases in the era of novel drugsJulian David Etessami, Giovanni Dalla Via, Emanuela Ferraro, et al.
Expert Opinion on Pharmacotherapy|May 22, 2026
Oral selective estrogen receptor degraders (SERDs) for the treatment of hormone receptor-positive, HER2-negative breast cancer title: oral selective estrogen receptor degraders (SERDs) for the treatment of hormone receptor-positive, HER2-negative breast cancerJulian David Etessami, Carmine Valenza, Pier Paolo Maria Berton Giachetti, et al.
Critical Reviews in Oncology/Hematology|April 12, 2026
Epidermal Growth Factor Receptor (EGFR) atypical mutations in Non-Small-Cell Lung Cancer (NSCLC): 'where the streets have no name'Gianluca Spitaleri, Pamela Trillo Aliaga, Gianluca Alessio Mariani, et al.
Pageof 1